Director of Small Molecule Therapeutics
Dr Lorna Mitchell is a medicinal chemist with 17 years international drug discovery experience in the biotech and pharmaceutical industry.
Lorna is passionate about delivering high quality drug candidates and has experience across a range of therapeutic areas including oncology, neuroscience, antivirals, and dermatology.
Lorna started her industry career, and training as a medicinal chemist, at Pfizer. She continued to grow her skill set within Pfizer for nearly 10 years at sites in both the USA and the UK before moving into the biotech arena. Lorna worked in various Boston area biotech’s for 7 years, with most of that time at Epizyme, before she relocated to Australia in 2017 as head of medicinal chemistry at Bionomics.
Lorna completed her Ph.D. in organic chemistry at The University of Auckland in New Zealand and carried out post-doctoral studies at the University of Rochester in the USA and the Auckland Cancer Society Research Centre (ACSRC) in New Zealand.